The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2020 Euromoney, a part of the Euromoney Institutional Investor PLC.

JPMorgan faces derivatives regulation hit

Revenues heavily weighted to OTC derivatives Worst-case guidance: JPM could face revenue loss of $3 billion a year

For a bank that weathered the financial crisis better than most of its peers it might seem slightly incongruous that JPMorgan should suffer the most from regulation aimed at curbing past excesses.

The biggest counterparty in the OTC derivatives market last month gave the first indications of how proposed regulation of derivatives traded outside exchanges could affect revenues. In a briefing with Sanford Bernstein banking analyst John McDonald, JPMorgan’s investment bank chairman Steve Black said the firm would face earnings headwinds if lawmakers had their way and moved trading of OTC derivatives such as interest rate swaps and credit default swaps onto exchanges. McDonald said JPMorgan’s investment bank revenues in a worst-case situation might fall by between $2 billion and $3 billion. That, after expenses, reserving costs and taxes, could reduce earnings per share by between 13 cents and 20 cents.

Percentage notional totals by type, Q2 2009

Take out a complimentary trial

Take out a 7 day trial to gain unlimited access to and analysis and receive expertly-curated updates direct to your inbox.


Already a user?

Login now


We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree